Institutional shares held 39.1 Million
100 calls
3.3K puts
Total value of holdings $25M
$0 calls
$2K puts
Market Cap $14.2M
23,300,900 Shares Out.
Institutional ownership 167.96%
# of Institutions 71


Latest Institutional Activity in ELEV

Top Purchases

Q4 2024
Allostery Investments LP Shares Held: 432K ($264K)
Q4 2024
Citadel Advisors LLC Shares Held: 266K ($162K)
Q4 2024
Stonepine Capital Management, LLC Shares Held: 200K ($122K)
Q4 2024
Deutsche Bank Ag\ Shares Held: 189K ($115K)
Q4 2024
Jpmorgan Chase & CO Shares Held: 180K ($110K)

Top Sells

Q4 2024
Goldman Sachs Group Inc Shares Held: 1.65M ($1.01M)
Q4 2024
Morgan Stanley Shares Held: 420K ($256K)
Q4 2024
Acadian Asset Management LLC Shares Held: 166K ($101K)
Q4 2024
Vanguard Group Inc Shares Held: 2.61M ($1.59M)
Q4 2024
Schonfeld Strategic Advisors LLC Shares Held: 333K ($203K)

About ELEV

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.


Insider Transactions at ELEV

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
113K Shares
From 4 Insiders
Exercise of conversion of derivative security 113K shares
Sell / Disposition
40.4K Shares
From 4 Insiders
Payment of exercise price or tax liability 40.4K shares

Track Institutional and Insider Activities on ELEV

Follow Elevation Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELEV shares.

Notify only if

Insider Trading

Get notified when an Elevation Oncology, Inc. insider buys or sells ELEV shares.

Notify only if

News

Receive news related to Elevation Oncology, Inc.

Track Activities on ELEV